About STAAR Surgical Co
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.staar.com/
Frequently Asked Questions
What is the 52-week range for STAA?
The 52-week high is $35.87 and the 52-week low is $15.59.
What is the P/E ratio for STAA?
The Price to Earnings (P/E) ratio is 292.65.
What is the dividend yield for STAA?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 1.08%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 1.13%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.41.
Analyst Recommendation Trends
Wall Street analyst consensus for STAA over the last few months:
Latest STAA News
STAAR Surgical: A Recovery Story Priced As Growth
STAAR Surgical (STAA) faces heavy China distributor risk, rising receivables, and premium valuation. Read here for a detailed investment analysis.
Why Staar Surgical Zoomed Almost 8% Higher on Tuesday
It was the subject of a recommendation upgrade from an analyst.
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know
Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 6.4% in the pre-market session after Stifel upgraded the company from Hold to Buy and lifted its price target to $31.00 from $28.00, StreetInsider reported.
STAAR Surgical jumps on Stifel upgrade citing China growth potential
Investing.com -- STAAR Surgical Company (NASDAQ:STAA) shares rallied 7% in early Tuesday trade following an upgrade from Stifel, which pointed to improving international sales momentum and favorable product mix trends. Analyst Thomas Stephan raised Stifel's rating on the ophthalmic medical device manufacturer to Buy from Hold while lifting its price target to $31 from $28.
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AutoZone, Baker Hughes, FS KKR Capital, Kroger, Netflix, PepsiCo, Ryder Systems, SpaceX, Warner Bros. Discovery, and More
Markets opened Tuesday on edge as surging oil prices, climbing Treasury yields, and a rejected Iran ceasefire rattled traders heading into the final stretch of Q3. Find out which major names on Wall Street got upgraded, downgraded, or freshly initiated before the opening bell.
STAAR Surgical Analyst Turns Bullish On Potential For ‘Meaningful’ Street Upside
Stifel upgraded STAAR Surgical to Buy, while raising its price target, citing China momentum, EVO+ mix and upside to 2026-27 estimates.
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target changes.
CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday
U.S. stocks mixed as Dow fell 100+ points; CarMax surged 9.7% on strong results, while Iovance, Carnival and others gained.
Robinhood To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Analysts cut targets for BOOT, MTN, SFIX, WU, NFLX and ROL; raised HOOD and STAA targets. SFIX upgraded to Neutral, NFLX to Buy.
Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $31
Stifel analyst Thomas Stephan upgrades Staar Surgical (NASDAQ:STAA) from Hold to Buy and raises the price target from $28 to $31.
Why Staar Surgical Stock Soared Today
It has launched a $50 million share repurchase program.
Sector Update: Healthcare Stocks Edge Higher Premarket Friday
Healthcare stocks were edging higher premarket Friday, with the State Street Health Care Select Sect
STAAR Surgical stock ticks higher on $50M buyback authorization
Investing.com -- STAAR Surgical Company (NASDAQ:STAA) shares rose as much as 2% in after-hours trading Thursday following the company's announcement of a $50 million share repurchase program authorized by its Board of Directors.
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
LAKE FOREST, Calif., September 24, 2026--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors, at a regularly scheduled meeting, authorized a share repurchase program under which the Company may repurchase up to $50 million of its outstanding common stock.
China-Led Rebound and New Leadership Might Change The Case For Investing In STAAR Surgical (STAA)
STAAR Surgical recently reported quarterly net sales of US$93.5 million, an increase of 111% year over year, driven largely by China where revenue more than doubled to US$52.3 million and helped swing the company to US$8.1 million in net income from a loss a year earlier. Alongside this earnings rebound, STAAR strengthened its leadership bench by appointing former CEO David Bailey as Chief Commercial Officer and Ben Park, Ph.D., as Chief Technology Officer, signaling a focus on accelerating...
STAAR Surgical (STAA) Swings To Profit, Is A 22% Undervalued View Justified?
Executive Changes Reframe STAAR Surgical After Turnaround Results STAAR Surgical (STAA) reported a sharp business turnaround, with net sales rising 111% year over year and net income reaching $8.1 million, helped by China now contributing more than half of revenue. That backdrop sets the stage for two fresh executive appointments at the ophthalmic device producer. These moves could shape how the recent performance is translated into longer term commercial and product decisions. On the market...
STAAR Surgical (STAA) Swings To Profit On China Rebound
On August 12, STAAR Surgical (NASDAQ:STAA) reported results for the quarter ended July 3 that flipped the script from a year earlier. Net sales jumped 111% year over year to $93.5 million, and the company that lost money in the same quarter of 2025 turned in $8.1 million of net income instead. It is the […]
STAAR Surgical hires former CEO to lead commercial team
David Bailey has rejoined STAAR after participating in the successful campaign to block Alcon’s takeover of the company.
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
LAKE FOREST, Calif., September 10, 2026--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today released a new report entitled The Future of Refractive Surgery, the first comprehensive global market analysis showing a consistent, multi-market migration toward implantable lens correction driven by durable tailwinds on the demand and clinical sides of the market.
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
LAKE FOREST, Calif., September 08, 2026--STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer. Mr. Bailey will join STAAR's executive committee and report to Warren Foust, President and Chief Executive Officer.
1 Russell 2000 Stock for Long-Term Investors and 2 Facing Challenges
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-14 | Foust Warren | +3,666 | - | - |
| 2026-08-14 | Foust Warren | +7,331 | - | - |
| 2026-08-14 | Foust Warren | +123,659 | - | - |
| 2026-08-14 | Foust Warren | +131,830 | - | - |
| 2026-08-14 | Foust Warren | +37,962 | - | - |
| 2026-08-14 | Foust Warren | +40,471 | - | - |
| 2026-08-14 | Foust Warren | +22,493 | - | - |
| 2026-08-14 | Foust Warren | -1,865 | $26.18 | $48,826 |
| 2026-08-14 | Foust Warren | +3,666 | - | - |
| 2026-08-14 | Foust Warren | -3,730 | $26.18 | $97,651 |
| 2026-08-14 | Foust Warren | +7,331 | - | - |
| 2026-08-14 | Michna Magda | +1,100 | - | - |
| 2026-08-14 | Michna Magda | +5,499 | - | - |
| 2026-08-14 | Michna Magda | +1,100 | $26.18 | $28,798 |
| 2026-08-14 | Michna Magda | -559 | $26.18 | $14,635 |
| 2026-08-14 | Michna Magda | -2,797 | $26.18 | $73,225 |
| 2026-08-14 | Michna Magda | +5,499 | - | - |
| 2026-08-14 | ANDREWS DEBORAH J | +5,233 | - | - |
| 2026-08-14 | ANDREWS DEBORAH J | +29,159 | - | - |
| 2026-08-14 | ANDREWS DEBORAH J | +8,952 | - | - |
| 2026-08-14 | ANDREWS DEBORAH J | +4,975 | - | - |
| 2026-08-14 | ANDREWS DEBORAH J | -2,662 | $26.18 | $69,691 |
| 2026-08-14 | ANDREWS DEBORAH J | +5,233 | - | - |
| 2026-07-31 | Foust Warren | -20,787 | - | - |
| 2026-07-31 | Foust Warren | -10,576 | $24.36 | $257,631 |
| 2026-07-31 | Foust Warren | +20,787 | - | - |
| 2026-07-31 | ANDREWS DEBORAH J | -20,787 | - | - |
| 2026-07-31 | ANDREWS DEBORAH J | -10,576 | $24.36 | $257,631 |
| 2026-07-31 | ANDREWS DEBORAH J | +20,787 | - | - |
| 2026-06-25 | ANDREWS DEBORAH J | -13,955 | - | - |
| 2026-06-25 | ANDREWS DEBORAH J | -6,480 | $31.21 | $202,241 |
| 2026-06-25 | ANDREWS DEBORAH J | +13,955 | - | - |
| 2026-06-18 | Wang Christopher Min Fang | +11,145 | - | - |
| 2026-06-18 | Zhou Lilian Yansheng | +5,572 | - | - |
| 2026-06-18 | Zhou Lilian Yansheng | +3,091 | - | - |
| 2026-06-18 | Jiang Wei | +6,182 | - | - |
| 2026-06-18 | Jiang Wei | -10,683 | - | - |
| 2026-06-18 | Jiang Wei | +10,683 | - | - |
| 2026-06-18 | Butcher Arthur C | +3,709 | - | - |
| 2026-06-18 | Butcher Arthur C | +4,458 | - | - |
| 2026-06-18 | Butcher Arthur C | -5,341 | - | - |
| 2026-06-18 | Butcher Arthur C | +5,341 | - | - |
| 2026-06-18 | LeBuhn Richard T. | +11,145 | - | - |
| 2026-06-18 | Bradsher Neal C | +11,145 | - | - |
| 2026-06-18 | SILVERMAN LOU | +6,182 | - | - |
| 2026-06-18 | SILVERMAN LOU | -10,683 | - | - |
| 2026-06-18 | SILVERMAN LOU | +10,683 | - | - |
| 2026-06-12 | Zhou Lilian Yansheng | +3,530 | $28.2904 | $99,865 |
| 2026-05-15 | Foust Warren | +3,666 | - | - |
| 2026-05-15 | Foust Warren | +7,331 | - | - |
| 2026-05-15 | Foust Warren | +7,331 | - | - |
| 2026-05-15 | Foust Warren | +14,662 | - | - |
| 2026-05-15 | Foust Warren | -1,865 | $32.07 | $59,811 |
| 2026-05-15 | Foust Warren | +3,666 | - | - |
| 2026-05-15 | Foust Warren | -3,730 | $32.07 | $119,621 |
| 2026-05-15 | Foust Warren | +7,331 | - | - |
| 2026-05-15 | Foust Warren | -3,730 | $32.07 | $119,621 |
| 2026-05-15 | Foust Warren | +7,331 | - | - |
| 2026-05-15 | Foust Warren | -7,460 | $32.07 | $239,242 |
| 2026-05-15 | Foust Warren | +14,662 | - | - |
| 2026-05-15 | Michna Magda | +1,100 | - | - |
| 2026-05-15 | Michna Magda | +2,199 | - | - |
| 2026-05-15 | Michna Magda | +5,499 | - | - |
| 2026-05-15 | Michna Magda | +10,997 | - | - |
| 2026-05-15 | Michna Magda | -559 | $32.07 | $17,927 |
| 2026-05-15 | Michna Magda | +1,100 | - | - |
| 2026-05-15 | Michna Magda | -1,118 | $32.07 | $35,854 |
| 2026-05-15 | Michna Magda | +2,199 | - | - |
| 2026-05-15 | Michna Magda | -2,431 | $32.07 | $77,962 |
| 2026-05-15 | Michna Magda | +5,499 | - | - |
| 2026-05-15 | Michna Magda | -5,595 | $32.07 | $179,432 |
| 2026-05-15 | Michna Magda | +10,997 | - | - |
| 2026-05-15 | ANDREWS DEBORAH J | +5,233 | - | - |
| 2026-05-15 | ANDREWS DEBORAH J | +10,466 | - | - |
| 2026-05-15 | ANDREWS DEBORAH J | -1,877 | $32.07 | $60,195 |
| 2026-05-15 | ANDREWS DEBORAH J | +5,233 | - | - |
| 2026-05-15 | ANDREWS DEBORAH J | -3,755 | $32.07 | $120,423 |
| 2026-05-15 | ANDREWS DEBORAH J | +10,466 | - | - |
| 2026-05-08 | Foust Warren | -3,448 | $26.69 | $92,027 |
| 2026-05-08 | Michna Magda | -1,680 | $26.69 | $44,839 |
| 2026-03-14 | Foust Warren | -9,775 | - | - |
| 2026-03-14 | Foust Warren | -19,550 | - | - |
| 2026-03-14 | Foust Warren | +9,775 | - | - |
| 2026-03-14 | Foust Warren | +19,550 | - | - |
| 2026-03-14 | Michna Magda | -2,932 | - | - |
| 2026-03-14 | Michna Magda | -14,663 | - | - |
| 2026-03-14 | Michna Magda | -6,313 | $18.84 | $118,937 |
| 2026-03-14 | Michna Magda | +2,932 | - | - |
| 2026-03-14 | Michna Magda | +14,663 | - | - |
| 2026-03-13 | Foust Warren | +45,117 | - | - |
| 2026-03-13 | Michna Magda | +33,838 | - | - |
| 2026-03-13 | ANDREWS DEBORAH J | +39,809 | - | - |
| 2026-03-13 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-03-13 | BROADWOOD PARTNERS, L.P. | +316,017 | $18.615 | $5,882,656 |
| 2026-03-12 | Foust Warren | -8,175 | - | - |
| 2026-03-12 | Foust Warren | +8,175 | - | - |
| 2026-03-12 | Michna Magda | -6,178 | - | - |
| 2026-03-12 | Michna Magda | -2,216 | $18.39 | $40,752 |
| 2026-03-12 | Michna Magda | +6,178 | - | - |
| 2026-03-12 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-03-12 | BROADWOOD PARTNERS, L.P. | +299,432 | $18.1154 | $5,424,330 |
| 2026-03-11 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-03-11 | BROADWOOD PARTNERS, L.P. | +54,764 | $17.5217 | $959,558 |
| 2026-03-06 | Wang Christopher Min Fang | +7,524 | - | - |
| 2026-03-06 | LeBuhn Richard T. | +7,524 | - | - |
| 2026-03-06 | Bradsher Neal C | +7,524 | - | - |
| 2026-02-02 | Foust Warren | +20,787 | - | - |
| 2026-02-02 | ANDREWS DEBORAH J | +20,787 | - | - |
| 2026-01-12 | Jiang Wei | -20,967 | - | - |
| 2026-01-12 | Jiang Wei | +20,967 | - | - |
| 2026-01-09 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-01-09 | BROADWOOD PARTNERS, L.P. | +27,485 | $22.0534 | $606,138 |
| 2026-01-08 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-01-08 | BROADWOOD PARTNERS, L.P. | +3,240 | $21.9389 | $71,082 |
| 2026-01-07 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-01-07 | BROADWOOD PARTNERS, L.P. | +66,467 | $22.0004 | $1,462,301 |
| 2026-01-06 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-01-06 | BROADWOOD PARTNERS, L.P. | +150,000 | $22.3756 | $3,356,340 |
| 2026-01-06 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2026-01-06 | BROADWOOD PARTNERS, L.P. | +186,946 | $21.0111 | $3,927,941 |
| 2025-12-11 | SISITSKY NATHANIEL | -2,616 | $24.68 | $64,563 |
| 2025-11-21 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2025-11-21 | BROADWOOD PARTNERS, L.P. | +797,486 | $27.8611 | $22,218,837 |
| 2025-11-20 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2025-11-20 | BROADWOOD PARTNERS, L.P. | +393,382 | $27.1373 | $10,675,325 |
| 2025-11-19 | BROADWOOD PARTNERS, L.P. | 0 | - | - |
| 2025-11-19 | BROADWOOD PARTNERS, L.P. | +309,132 | $26.4164 | $8,166,155 |
| 2025-11-12 | Jiang Wei | -20,967 | - | - |
| 2025-11-12 | Jiang Wei | +20,967 | - | - |